APO Research
Talk to an analyst

APO RESEARCH · REPORT

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Outlook and Growth Opportunities 2026

19 December 2025196 pages

Choose your research edition.

Industry ResearchLow Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Research Report 2026101 pages · $2,950 USDIndustry Growth & TrendsGlobal Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market include Takeda, Xencor, Inc., MacroGenics, Inc. and BioInvent International AB, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market.

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Segment by Company

Takeda

Xencor, Inc.

MacroGenics, Inc.

BioInvent International AB

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Segment by Type

BI-1206

MGD-010

SM-201

XmAb-7195

Others

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Segment by Application

Hospital

Clinic

Others

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b key companies, revenue, market share, and recent developments.

3. To split the Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b significant trends, drivers, influence factors in global and regions.

6. To analyze Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b industry.

Chapter 3: Detailed analysis of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Trends Table 2. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Drivers Table 3. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Opportunities and Challenges Table 4. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Restraints Table 5. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue Share by Company (2021-2026) Table 7. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Key Company Manufacturing Base & Headquarters Table 9. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company, Product Type & Application Table 10. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of BI-1206 Table 15. Significant Companies of MGD-010 Table 16. Significant Companies of SM-201 Table 17. Significant Companies of XmAb-7195 Table 18. Significant Companies of Others Table 19. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type (2021-2026) Table 23. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Table 25. Significant Companies of Clinic Table 26. Significant Companies of Others Table 27. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application (2021-2026) Table 31. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application (2027-2032) Table 32. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Region (2021-2026) Table 35. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Region (2027-2032) Table 37. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Market Share by Country (2021-2026) Table 40. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Market Share by Country (2027-2032) Table 42. Takeda Company Information Table 43. Takeda Business Overview Table 44. Takeda Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Takeda Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio Table 46. Takeda Recent Development Table 47. Xencor, Inc. Company Information Table 48. Xencor, Inc. Business Overview Table 49. Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio Table 51. Xencor, Inc. Recent Development Table 52. MacroGenics, Inc. Company Information Table 53. MacroGenics, Inc. Business Overview Table 54. MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio Table 56. MacroGenics, Inc. Recent Development Table 57. BioInvent International AB Company Information Table 58. BioInvent International AB Business Overview Table 59. BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio Table 61. BioInvent International AB Recent Development Table 62. Research Programs/Design for This Report Table 63. Authors List of This Report Table 64. Secondary Sources Table 65. Primary Sources List of Figures Figure 1. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Image Figure 2. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size (2021-2032) & (US$ Million) Figure 4. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. BI-1206 Image Figure 8. MGD-010 Image Figure 9. SM-201 Image Figure 10. XmAb-7195 Image Figure 11. Others Image Figure 12. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type (2021-2032) Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Others Image Figure 18. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application (2021-2032) Figure 21. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032) & (US$ Million) Figure 24. North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032) & (US$ Million) Figure 30. South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • BI-1206
  • MGD-010
  • SM-201
  • XmAb-7195
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda
  • Xencor, Inc.
  • MacroGenics, Inc.
  • BioInvent International AB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Dynamics
  1. 2.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Trends
  2. 2.2 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Drivers
  3. 2.3 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Opportunities and Challenges
  4. 2.4 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Industry Restraints
3 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market by Company
  1. 3.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company Revenue Ranking in 2025
  2. 3.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue by Company (2021-2026)
  3. 3.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company Ranking (2024-2026)
  4. 3.4 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company Manufacturing Base and Headquarters
  5. 3.5 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company Product Type and Application
  6. 3.6 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market by Type
  1. 4.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Type Introduction
  2. 4.1.1 BI-1206
  3. 4.1.2 MGD-010
  4. 4.1.3 SM-201
  5. 4.1.4 XmAb-7195
  6. 4.1.5 Others
  7. 4.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Type
  8. 4.2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Type (2021-2032)
  10. 4.2.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type (2021-2032)
5 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market by Application
  1. 5.1 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Application
  6. 5.2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Application (2021-2032)
  8. 5.2.3 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application (2021-2032)
6 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Regional Value Analysis
  1. 6.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Region (2021-2032)
  3. 6.2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Region: 2021-2026
  4. 6.2.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032)
  7. 6.3.2 North America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032)
  10. 6.4.2 Europe Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032)
  16. 6.6.2 South America Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Country, 2025 VS 2032
7 Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Country-level Value Analysis
  1. 7.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Country (2021-2032)
  3. 7.2.1 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Country (2021-2026)
  4. 7.2.2 Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Xencor, Inc.
  8. 8.2.1 Xencor, Inc. Company Information
  9. 8.2.2 Xencor, Inc. Business Overview
  10. 8.2.3 Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xencor, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio
  12. 8.2.5 Xencor, Inc. Recent Developments
  13. 8.3 MacroGenics, Inc.
  14. 8.3.1 MacroGenics, Inc. Company Information
  15. 8.3.2 MacroGenics, Inc. Business Overview
  16. 8.3.3 MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MacroGenics, Inc. Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio
  18. 8.3.5 MacroGenics, Inc. Recent Developments
  19. 8.4 BioInvent International AB
  20. 8.4.1 BioInvent International AB Company Information
  21. 8.4.2 BioInvent International AB Business Overview
  22. 8.4.3 BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BioInvent International AB Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Product Portfolio
  24. 8.4.5 BioInvent International AB Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst